The China Liquid Biopsy Market has experienced remarkable growth in recent years, driven by increasing cancer incidence, growing demand for non-invasive molecular diagnostics, and expanding government support for precision medicine and innovative medical device development. These advanced diagnostic platforms analyze circulating tumor DNA, circulating tumor cells, and exosomes from blood...